We showed that losartan exhibited a protective effect on DN, suppressing phosphorylation of ERK1/2 and TGF-β1 expression, which also occurred in the previous observations in animals and patients (Siragy and Huang, 2008; Huang et al., 2011; Anbar et al., 2016). The gene discussed is MAPK3; the disease is liver dysplastic nodule.